PL EN


2019 | 2 | 153–156
Article title

Neoadjuvant therapy in breast cancer – objectives and tasks

Content
Title variants
Languages of publication
EN
Abstracts
EN
Introduction. Neoadiuvant therapy (NCT) in the treatment of breast cancer is employed for patients with early stage disease or with inoperable disease. NCT can decrease the tumor volume. It can facilitate breast conservation therapy. Response to NCT is a strong predictor of outcome breast cancer (BC). Direct target therapies has markedly improved the result of treatment BC. Aim. Therapy for breast cancer continues to improve. The importance of tumor burden on local control rates will be in the future. Material and methods. This analysis was performed using a systematic literature search. Results. The latest scientific reports give hope for greater safety and a better life for patients based on optimized and effective therapy. Conclusion. Currently, improving the effectiveness of breast cancer treatment is mainly related to the optimal use of classic therapeutic strategies. New classes of substances have been approved for treatment or are in advanced stages of clinical development.
Year
Issue
2
Pages
153–156
Physical description
Contributors
  • Clinical Department of Pathomorphology, Clinical Hospital No. 1 in Rzeszów, Rzeszów, Poland
  • Department of Biochemistry and General Chemistry, Faculty of Medicine, University of Rzeszów, Rzeszów, Poland
  • Department of Photomedicine and Physical Chemistry, Faculty of Medicine, University of Rzeszów, Rzeszów, Poland
author
  • Clinical Department of Pathomorphology, Clinical Hospital No. 1 in Rzeszów, Rzeszów, Poland
References
Document Type
Publication order reference
Identifiers
YADDA identifier
bwmeta1.element.mhp-da1c7b6b-f852-4f7c-bdeb-77b96fda925e
JavaScript is turned off in your web browser. Turn it on to take full advantage of this site, then refresh the page.